| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |